← All trials
NCT03898505
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 24, 2017
- Primary completion
- Jun 25, 2018
- Completion date
- Aug 1, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 30
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of GuelphLead sponsor
- University of GuelphStudy director
- University of GuelphOverall official - principal investigator
- University of GuelphReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.